|
|
|
A Long Shot on CytomegalovirusGerd Maul was frustrated. It was 1989, and the German-born researcher at Philadelphia's Wistar Institute couldn't develop antibodies to the nuclear pore proteins that had been a focus of his study for nearly a decade. With funding getting tight, he consulted a colleague, Sergio Jimenez, then across the street at the University of Pennsylvania, who worked with patients with the |
|
|
|
|
|
|||||||||
|
|||||||||
|